Follow

Completion of patents to international markets

13 October 2021 - 09:00

iZafe Group AB (publ) (”iZafe” or ”the Company”) announces that they have filed for several completions of their PCT patent application. Thus, the Company enables a greater geographic patent protection, which is part of iZafe’s strategy to strengthen and further develop its intangible assets internationally.

The scope of protection in question refers to the pharmaceutical robot Dosell and its services. The application has been submitted for protection in key markets that iZafe has identified and wherein iZafe has seen great demand for Dosell. These markets are Europe, the United States, Russia and China. The extensive geographic patent protection is sought in order to prepare for the international expansion that is planned to be executed after the ongoing rights issue.

“The pharmaceutical robot Dosell is perceived as simple and easy to use, both for the user and the caregiver, and this combined with an affordable price has led to us seeing a great potential internationally for both our corporate version and the consumer version. It is therefore crucial to work strategically with our intangible assets as we expand the business.” says Anders Segerström, CEO of iZafe Group.

Furthermore, the Company has filed an international patent application regarding advanced, digitalized and smart functions that provide a more intelligent and adaptable version of Dosell.

By using sensors and other digital care equipment in the home and regularly measuring patient-specific data, the system provides even safer medication for patients. The international patent application enables iZafe to obtain patents in more than 150 countries. The current patent application creates a strong basis for patent protection in selected markets, including Sweden, the whole of Europe, Asia and the United States.

Provided by: MFN
Nasdaq First North GM (Sweden)
iZafe Group
iZafe is a pure Life-Science company engaged in the development of digital drug dispensing. The Company conducts research, development and marketing of digital medical solutions and services for safer drug management at home....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More